Region — International. Neutral scientific reference — not offered for sale here.
Cart · 0
Set region
Explore  /  Mandelic Acid
Research reference — not for sale

Mandelic Acid

B
lead outcome
Gentle exfoliation & smoothing (appearance)
grades vary by outcome ↓
Small molecule (non-peptide)
also called — INCI: Mandelic Acid · DL-mandelic acid · alpha-hydroxyphenylacetic acid · amygdalic acid · C8H8O3
skin appearance (cosmetic)exfoliation (appearance)brightening (appearance)
In brief

Mandelic acid is the gentlest common AHA — the largest molecule (~152 Da, from bitter almonds), so it penetrates the slowest and irritates the least. That gentleness is the whole point: it exfoliates for smoother, brighter-looking skin, but with a notably lower risk of the dark marks that harsher acids like glycolic can trigger in melanin-rich skin, making it the preferred first-line AHA for deeper skin tones, sensitive and reactive skin, and acid beginners. The trade-off is that gentle also means milder — for maximum resurfacing on tolerant skin, glycolic is stronger. It supports a more even-looking tone by lifting surface pigment and slowing pigment production, but the treatment-style claims ("treats acne/melasma", "inhibits tyrosinase") stay out of the cosmetic claims. It is a distinct molecule from glycolic and lactic acid. As with all AHAs, daily sunscreen is essential.

Legal standing, by region
International
Lawful cosmetic ingredient

Mandelic Acid (INCI) is a lawful cosmetic ingredient worldwide, including the EU (Regulation (EC) 1223/2009); CosIng-listed (AHA leave-on products carry standard "increases sun sensitivity / use SPF" labelling). A distinct molecule from the other AHAs — glycolic and lactic acid are NOT synonyms. Generally well tolerated; the gentlest of the common AHAs.

Evidence, by outcome
How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Gentle exfoliation & smoothing (appearance)
Gentle means effective-but-mild, not miraculous — for maximum resurfacing on tolerant skin, glycolic remains stronger. Like all AHAs it raises sun sensitivity; daily SPF is essential.
Mandelic acid is the largest common AHA (~152 Da, from bitter almonds), so it penetrates the slowest and most evenly — the gentlest chemical exfoliant, with much less sting than glycolic. It loosens dead surface cells for smoother-looking texture and brighter tone, and topical studies report improved skin viscoelasticity. · Smoother-, more even-looking skin with gentle, gradual exfoliation; a strong entry point for acid beginners and reactive skin
B
Brightness & even-tone appearance
Appearance of tone only — not a treatment for hyperpigmentation or melasma (stubborn, often hormonal — a dermatologist's remit). The pigment-enzyme mechanism stays in the reference; it is not a cosmetic claim.
Mandelic acid supports a brighter, more even-looking tone two ways: by lifting surface pigment through gentle exfoliation, and by slowing pigment production (its reference-layer mechanism; see the body). Clinical benchmarks suggest mandelic peels can rival glycolic for the look of discolouration while staying gentler. · A more even, brighter-looking complexion; helps the look of post-blemish marks
B
Suits sensitive & melanin-rich skin (lower irritation / lower dark-mark risk)
Lower risk, not zero — patch-test, ease in, and keep SPF daily.
Its standout property: because it penetrates so slowly and irritates so little, it carries a lower risk of the post-inflammatory hyperpigmentation that harsher acids can trigger in richer skin tones — making it a preferred first-line AHA for deeper tones (Fitzpatrick III-VI), sensitive, reactive, and rosacea-prone skin. · Gentle resurfacing that suits skin where stronger acids risk new marks
B
"Treats acne / hyperpigmentation / melasma; inhibits tyrosinase; antibacterial"
Mandelic acid has mild antibacterial, comedolytic and pigment-enzyme mechanisms in the reference literature, but "treats acne", "treats melasma", "inhibits tyrosinase" and "antibacterial" are treatment/drug-style claims, firewalled out. Persistent acne or melasma is a dermatologist's remit.
Outside cosmetic scope
D
Disclosure

Vallydia sells its own cosmetic serums, and some ingredients graded here belong to the same categories as those products. Grades are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.

Trade names shown here (for example Matrixyl, Argireline, Syn-Ake) are the property of their respective owners and are used only to identify the ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor.

Evidence changes

Get notified if this changes

We track new research and update these grades as the evidence moves. Leave your email and we'll tell you if the evidence for Mandelic Acid changes - nothing else.

One ingredient, one purpose. No marketing, no sharing. Unsubscribe anytime. See our privacy policy.

Cosmetic claims boundary
✓ Allowed (appearance / feel)
  • gentle exfoliation for smoother-looking skin
  • helps the look of brightness and a more even tone
  • suits sensitive skin and darker tones (lower irritation)
  • a gentle entry point to exfoliating acids
  • helps soften the look of post-blemish marks over time
✕ Not allowed (medicinal)
  • treats acne
  • treats hyperpigmentation
  • treats melasma
  • inhibits tyrosinase
  • anti-inflammatory
  • antibacterial

The medicinal-sounding science stays in the reference section; product copy speaks only to appearance/feel (Reg 655/2013). Different fields, never merged.

Identity

Mandelic acid is an alpha-hydroxy acid (AHA) derived from bitter almonds. What sets it apart from its AHA cousins is size: at roughly 152 Da it is the largest common AHA — nearly twice the size of glycolic acid — so it diffuses through the skin's surface far more slowly and evenly. That slowness is the source of everything that makes it special: it is the gentlest chemical exfoliant, and, importantly, the one with the lowest risk of provoking dark marks in richer skin tones.

It is a distinct molecule. Glycolic and lactic acid are not synonyms of mandelic acid — they are separate AHAs with their own, faster, stronger profiles. The cosmetic material is typically the racemate (DL-mandelic acid).

Development & history

  • Glycolic acid dominates the AHA conversation, but mandelic acid earned a place as the low-drama option — the AHA for people who found glycolic too harsh.
  • Its most valuable, well-recognised property is the lower dark-mark risk for melanin-rich and reactive skin, where the irritation of faster acids can itself cause new pigmentation.
  • It is used at roughly 5% (starter) up to ~10% (OTC), at night, always with daily sunscreen — because, like all AHAs, it increases sun sensitivity.

Mechanism (as proposed)

Mandelic acid works as a gentle keratolytic exfoliant: it loosens the bonds between dead surface cells so they shed, smoothing texture and lifting surface pigment — but because it penetrates slowly, it does so with far less of the tingle, redness, and barrier stress of smaller acids. Studies report improved skin viscoelasticity (a measure of texture) with topical use.

Its support for a more even, brighter-looking tone comes from two directions: the exfoliation lifts existing surface pigment, and — in the reference literature — it slows melanin production (via inhibition of the pigment-forming enzyme tyrosinase). That enzyme mechanism belongs to the reference layer and is described here as such; the cosmetic claim stays at the level of appearance — the look of brightness and even tone — never "inhibits tyrosinase" or "treats" pigmentation.

The standout benefit is a consequence of the gentleness: slow penetration means little irritation, and little irritation means a lower risk of post-inflammatory hyperpigmentation — the dark marks that harsher exfoliation can trigger in deeper skin tones. That makes mandelic acid the sensible first-line AHA for Fitzpatrick III–VI, sensitive, reactive, and rosacea-prone skin, and for anyone new to acids. Reference-layer mechanisms (mild antibacterial, comedolytic, sebum-reducing action relevant to congestion) are noted but not claimed: persistent acne or melasma is a dermatologist's remit, and this is a cosmetic entry about the look and feel of smoother, brighter skin.

Chemical identifiers

Cross-reference identifiers for the authoritative external databases — not a recipe, and nothing about how to use it.

PubChem CID1292
InChIKeyIWYDHOAUDWTVEP-UHFFFAOYSA-N
SMILESC1=CC=C(C=C1)C(C(=O)O)O

via PubChem exact-name match (DL-mandelic acid, CID 1292) — cosmetic material is typically the racemate. · high confidence

Sources — 3 cited
01Taylor MB. Summary of mandelic acid for the improvement of skin conditions. Cosmet Dermatol. 1999; 12:26-28.
02Sarkar R, Ghunawat S, Garg VK. Comparative study of 35% glycolic acid, 20% salicylic- mandelic acid, and phytic acid combination peels in melasma. J Cutan Aesthet Surg. 2019; 12(3):158-163.
03Garg VK, Sinha S, Sarkar R. Glycolic acid peels versus salicylic-mandelic acid peels in active acne vulgaris and post-acne scarring and hyperpigmentation. Dermatol Surg. 2009; 35(1):59-65.
Updated 2026-07-25

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
Niacinamide (Vitamin B3)A
Small molecule (non-peptide)
Hyaluronic Acid (Sodium Hyaluronate)A
Polysaccharide
CeramidesA
Small molecule (non-peptide)
Explore by goal
Skin & aesthetic
Vallydia

A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.

RegionInternational
ExploreRegisterThe Register — full indexCategoriesTrust & COAHow we gradeOpen data
ShopCosmetic peptidesJournalQuizzes
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.